PHAXIAM Therapeutics announces a reverse share split of its shares

PHAXIAM announces the implementation of the reverse share split of the shares composing the Company’s share capital, by decision of the CEO on July 26th, 2023, following the sub-delegation granted by the Board of Directors on June 23rd, 2023, taken in accordance with the 23rd extraordinary resolution of the General Shareholders’ Meeting of June 23rd, 2023.